BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15028317)

  • 1. Differentiated thyroid cancer and outcome in iodine deficiency.
    Gyory F; Balazs G; Nagy EV; Juhasz F; Mezosi E; Szakall S; Math J; Lukacs G
    Eur J Surg Oncol; 2004 Apr; 30(3):325-31. PubMed ID: 15028317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
    Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of lymph node metastases in follicular thyroid cancer.
    Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
    World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
    Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
    Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors influencing survival after surgical treatment of well differentiated thyroid cancer].
    Nowak W; Szybiński P; Nowak K; Stachura J; Popiela T
    Wiad Lek; 2004; 57(9-10):431-7. PubMed ID: 15765757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
    Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
    J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global variation in the pattern of differentiated thyroid cancer.
    Woodruff SL; Arowolo OA; Akute OO; Afolabi AO; Nwariaku F
    Am J Surg; 2010 Oct; 200(4):462-6. PubMed ID: 20887838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
    Machens A; Holzhausen HJ; Dralle H
    Cancer; 2005 Jun; 103(11):2269-73. PubMed ID: 15856429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.
    Haigh PI; Urbach DR; Rotstein LE
    Surgery; 2004 Sep; 136(3):609-16. PubMed ID: 15349109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.